Main results
Pooled data indicated a beneficial effect of cognitive reframing interventions on carers' psychological morbidity, specifically anxiety (standardised mean difference (SMD) -0.21; 95% confidence interval (CI) -0.39 to -0.04), depression (SMD -0.66; 95% CI -1.27 to -0.05), and subjective stress (SMD -0.23; 95% CI -0.43 to -0.04). No effects were found for carers' coping, appraisal of the burden, reactions to their relatives' behaviors, or institutionalization of the person with dementia.
Authors' conclusions
Cognitive reframing for family carers of people with dementia seems to reduce psychological morbidity and subjective stress but without altering appraisals of coping or burden. The results suggest that it may be an effective component of individualised, multi-component interventions for carers. Identifying studies with relevant interventions was a challenge for this review. The impact of cognitive reframing might be higher when used alongside other interventions because this offers better opportunities to tailor cognitive reframing to actual everyday carer problems.
P L A I N L A N G U A G E S U M M A R Y

Cognitive reframing for carers of people with dementia
There is some evidence that cognitive reframing interventions for family carers of people with dementia are effective.
Dementia care is challenging for family carers. We studied whether they could be helped by cognitive reframing interventions. Cognitive reframing is intended to reduce carers' stress by changing certain of their beliefs, such as beliefs about their responsibilities to the person with dementia, their own need for support, and why their relatives behave as they do. We found that cognitive reframing has the potential to reduce anxiety, depression and stress. It did not affect carers' coping or sense of being burdened. This review concludes that cognitive reframing might be useful to improve the mental health of informal carers of people with dementia.
B A C K G R O U N D
Dementia is primarily a disease of older people, particularly those over 80 years. The number of people with dementia in Europe is currently 7.7 million and will double by the year 2050 (EuroCoDe 2009). Dementia is now recognized as a major public health issue. According to the World Health Organization (WHO), Alzheimer's disease and other dementias are rated as the fourth leading cause of burden of disease in high-income countries (WHO 2008) . Dementia has a significant economic impact on health and social care services (Wimo 2007) . The costs to social and healthcare organizations and the impact on families are expected to escalate in the coming decades. Preventing or minimizing the effects of family carer burden and stress are key government priorities. Family carers of people with dementia experience more burden than family carers of other people with chronic illness (Draper 1992), and they are at greater risk of developing depression (Joling 2010). Carer burden is associated with patients' behavioral problems (Machnicki 2008; van den Wijngaart 2007; Vernooij-Dassen 1997) and is a strong predictor of institutionalization (Gaugler 2008; Vernooij-Dassen 1997) .
The balance of evidence about whether psychosocial interventions for caregivers of people with dementia could reduce carers' psychological morbidity and delay their relatives' institutionalization is now widely regarded as moderately positive (Brodaty 2003; Spijker 2008) . Psychosocial interventions for family carers are more successful when they are tailor-made, include the person with dementia as well as the caregiver, offer a choice of interventions and are intensive (Brodaty 2003; Spijker 2008) . However, these kinds of interventions involve multiple mechanisms of action. It is timely to try to identify the key ingredients responsible for the efficacy.
A key problem in dementia care is understanding and responding to the patient's behavior. Family carers often struggle to understand the cognitive decline and changing behavior of their loved one, often ascribing a negative meaning to their relative's behavior and blaming the person rather than the disease. Today we know that a person's behavior is often the result of an unmet (physical or psychosocial) need or a function of their interaction with a challenging physical or psychosocial environment. Not understating why their relative with dementia is behaving differently often leads family carers to experience distressing emotional states such as anger, anxiety, guilt and depression. While people can change the meanings or attributions they ascribe to situations, this often does not happen spontaneously. The positive effects of cognitive therapy, including cognitive restructuring, on a variety of stressrelated disorders (Gale 2000; Tolin 2010) suggest that it has potential for addressing the similar psychological morbidity of family carers of people with dementia. When used in psychosocial interventions for family carers, cognitive reframing focuses on changing self-defeating or distressing cognitions into those cognitions that support adaptive behaviour and reduce anxiety, depression and stress.
The theoretical framework of 'symbolic interactionism' is helpful in explaining how cognitive reframing might work. It states that the meaning people ascribe to a situation, in this case caring, is crucial to understanding how they will react. People tend to act upon the meaning they attribute to that situation. One of the assumptions of this theoretical perspective is that people are able to reflect on these attributions and to change them (Blumer 1969) . This theoretical framework offers a perspective which when viewed alongside the work of Lazarus (Lazarus 1984) and Bandura (Bandura 1977) enables us to describe the mechanism whereby psychological morbidity develops in carers and, consequently, to identify ways to alleviate it.
Cognitive reframing focuses on altering maladaptive, self-defeating or distressing cognitions and makes them more adapted to the situation. This, in turn, is assumed to improve coping, reduce burden and psychological morbidity, improve quality of life and reduce healthcare costs. Thus cognitive reframing is hypothesized to:
• improve family carers' coping and self-efficacy, reduce family carers' burden, change family carers' appraisal of their relatives' behaviors;
• reduce family carers' psychological morbidity (including depression and anxiety) and stress;
• increase family carers' quality of life;
• reduce healthcare costs, particularly by preventing or delaying institutionalization.
The review aimed to clarify the effectiveness of cognitive reframing and thus provide a clear evidence base for clinical practice. 
O B J E C T I V E S
Types of participants
The participants were family carers taking care of a person with any type of dementia. The relationship of the family carer to the person with dementia was spouse, child, other family member or friend. Only interventions involving family carers of communitydwelling people with dementia have been considered for inclusion.
Types of interventions
An intervention was accepted as 'cognitive reframing' if the authors specified the main goal of the intervention as being the reduction of caregiver problems, as named above, by means of the identification and modification of some or all of the following:
• family carers' beliefs about their own responsibilities to the people with dementia;
• family carers' beliefs about their own need for support and assistance;
• family carers' interpretations of the behaviors of the people with dementia.
The interventions could be provided in a group or individual setting. No restrictions with regard to types of control interventions (usual care or placebo intervention) have been made.
Types of outcome measures
The outcomes were divided into the following. 1. Psychological morbidity and distress of the family carers, including depression and anxiety. 2. Quality of life of the family carers. 3. Family carers' appraisal of their role performance including burden, coping and self-efficacy, and appraisal of problem behaviors. 4. Healthcare utilisation outcomes of the person with dementia, including admission to residential care or number of general practice visits.
Search methods for identification of studies
The trials were identified from a search of the Cochrane Dementia and Cognitive Improvement Group Specialized Register on 5 April 2009. This register contains records from the following major healthcare databases: The Cochrane Library, MEDLINE, EMBASE, PsycINFO, CINAHL and LILACS; and many ongoing trial databases and other grey literature sources. For more detailed information on what the Group's specialized register contains, and to view the search strategies used to retrieve records, see the Cochrane Dementia and Cognitive Improvement Group methods used in reviews. The Cochrane Library, MEDLINE, EMBASE, PsycINFO, CINAHL, LILACS and a number of trial registers and grey literature sources were also searched separately on 5 April 2009. The search strategies used to identify relevant controlled trials for this review can be found in Appendix 1.
Data collection and analysis
Selection of studies
Two review authors (MVD, ID) screened titles and abstracts and eliminated those clearly not relevant to this review. When the title and abstract did not provide all the information concerning the criteria, full paper copies were retrieved and screened. Authors of studies were contacted when additional information was required to assess whether the studies met the criteria for inclusion. Three review authors (MVD, ID and JMcC) screened the remaining studies for their eligibility and discussed them in accordance with the above defined criteria. Any disagreements about the selection of a trial were resolved by consensus. For one study, no agreement could be reached. Therefore, this study was independently assessed by Professor Linda Teri, acting as a contact editor of the Cochrane Dementia and Cognitive Improvement Group. Reasons for excluding any trial are detailed in the 'Characteristics of excluded studies'. Trials were not assessed blind as we knew the author's name and institution and the source of publication.
Data extraction and management
We extracted data from published reports using a standard form. The data used to measure outcomes in clinical trials of dementia and cognitive impairment were often ordinal. Where the rating scales used in the trials had a reasonably large number of categories (four or more) the data were treated as continuous and arising from a normal distribution. Summary statistics (n, mean and standard deviation) were required for continuous outcomes, for both the treatment and the control groups in each trial. Where possible, the outcomes were changes from baseline.
When change from baseline results were not reported, we calculated the required summary statistics from the baseline and assessment time group means and standard deviations, assuming a 0.4 correlation between the measurements at baseline and follow-up assessment. This method overestimates the standard deviation of the change from baseline. Such a conservative approach is preferable in a meta-analysis (http://ims.cochrane.org/revman/ documentation/rm5userguide.pdf). The baseline assessment is defined as the latest available assessment prior to randomisation, but no longer than two months prior. For dichotomous outcomes, the number with the outcome of interest, such as institutionalization, was extracted for the treatment and control groups. For each outcome measure, we sought data on every patient randomised. To allow an intention-to-treat analysis, the data were sought irrespective of compliance and whether or not the patient was subsequently deemed ineligible or otherwise excluded from treatment or follow-up.
Assessment of risk of bias in included studies
Quality assessment
The internal validity of trials is related to how successfully selection, performance, attrition and detection biases are eliminated. The methodological quality of the included studies was assessed and reported according to the methods set out in section 7 of the Cochrane Handbook for Systematic Reviews of Interventions (Higgins2009), which recommends the evaluation of selection bias, performance bias, detection bias and attrition bias. Each source of potential bias was assessed with respect to the following quality elements: randomisation, sequence generation and baseline comparability (selection bias); blinding of participants or providers, or both (performance bias); blinding of outcome assessors (detection bias); reporting of attrition rate, and the use of intention-to-treat analyses (attrition bias). Each parameter of trial quality was graded: A (adequate); B (unclear); C (inadequate). In most quality rating scales blinding is evaluated on several levels, such as blinding of patients and therapists or care providers. These scales are often used to test the quality of placebo-controlled medication studies. However, it is nearly impossible to blind the participants in a psychosocial intervention trial to the intervention to which they have been assigned and obviously impossible to blind the therapists to the intervention that they are delivering, but detection bias can be prevented by blinding of outcome assessors. Thus, blinding of patients and therapists was not included as one of the quality criteria but blinding of outcome assessors was included. Two review authors (MVD, ID) and a research assistant (FB) independently assessed the methodological quality of the selected studies. One review author (ID) and a research assistant (FB) extracted the data, checked for discrepancies and processed the data as described in Higgins 2005 (Higgins 2005). All studies were included in the initial analysis and if at risk of bias then excluded in the sensitivity analysis.
Process analysis
In practice, compliance with the intervention protocol might be problematic. The specific intervention activities and the actual exposure of the therapists and patients to these activities may influence results and effectiveness (Hulscher 2003) . Therefore we also assessed whether or not a process analysis had been performed (Hulscher 2003) .
Measures of treatment effect
Meta-analysis requires the combination of data from trials that may not use the same rating scale or test to assess an outcome. To accommodate this heterogeneity, the measure of the treatment difference for any outcome was the weighted mean difference when the pooled trials used the same scale, and the standardised mean difference (the absolute mean difference divided by the standard deviation) when they used different scales. For binary outcomes such as institutionalization or no institutionalization, we used either the odds ratio or the risk difference to measure treatment effect and calculated a weighted estimate of the typical treatment effect across trials.
Unit of analysis issues
The level at which the randomisation occurs must be taken into account. In most circumstances the number of observations will match the number of 'units' that were randomised. Cluster randomised trials were only considered if the reported analysis correctly accounted for the clustering. If a trial included repeated measurements, then care was taken not to include multiple measurements from the same trial in a single analysis. For crossover trials, only data from the first treatment period were included.
Dealing with missing data
When changes from baseline results were not reported, we calculated the required summary statistics from the baseline and assessment time treatment group means and standard deviations. In this case we assumed a 0.4 correlation between the measurements at baseline and assessment time.
Assessment of heterogeneity
Heterogeneity refers to the variability among the studies included in the systematic review. We considered heterogeneity among participants (for example age and relationship with patient), interventions and outcomes. As these factors varied between studies, they may affect the study effects. We performed tests for heterogeneity using a standard Chi 2 statistic and an I 2 statistic. Studies were considered heterogeneous if P ≤ 0.05. In general, this meant I 2 > 50%.
Assessment of reporting biases
The extent of publication bias was to be assessed through visual inspection of asymmetry. All studies were included in the initial analysis and then excluded in sensitivity analyses if at risk of bias.
Data synthesis
We presented overall estimates of the treatment difference. In all cases our aim was to present the overall estimate from a fixed-effect model. Where there was substantial heterogeneity of the treatment effect between trials (I 2 > 50%) then we either: 1) pooled only homogeneous results; or 2) used a random-effects model (in which case the confidence intervals would be wider than those of a fixedeffect model).
Subgroup analysis and investigation of heterogeneity
Analyses of groups of different types of participants distinguished in the included studies were reported. Since most psychosocial intervention studies had low numbers of participants, it was not possible to extract sufficient comparable data to undertake a meaningful subgroup analysis.
Sensitivity analysis
As stated in Module 14 of the Cochrane Collaboration open learning material (http://www.cochrane-net.org/openlearning/ HTML/mod14-2.htm), sensitivity analyses involved comparing the results of two or more meta-analyses calculated using different assumptions in order to assess the robustness of the results to the method used. The assumptions may concern a study's poorer quality, doubtful eligibility, outlier studies, imputed missing information, size of the trial, etc. We performed sensitivity analysis where in doubt.
R E S U L T S Description of studies
See: Characteristics of included studies; Characteristics of excluded studies. Eleven trials were identified that met inclusion criteria. See the 'Characteristics of included studies'.
Participants
Participants were family carers of people with dementia. Family carers' ages ranged from 19 to 84 years; the average age was 59 years. The relationship to the person with dementia was spouse (40.2%), adult child (28.1%) and other (6.7%). For 25% of the carers no relationship to the person with dementia was specified.
Interventions and theoretical models used
The included studies used the following theoretical models: the stress coping model (Beauchamp 2005; Farran 2007; Hebert 2003; Hepburn 2005) , the stress management model (Zarit 1987) and the cognitive behavioral therapy (CBT) model (Akkerman 2004; Chang 1999; Coon 2003; Gallagher-Thompson 2007; Marquez-Gonzalez 2007; Marriott 2000) .
In the stress coping model, individuals faced with a stressor make two appraisals, referred to as the primary and secondary appraisal. The primary appraisal involves an assessment of how stressful or threatening the situation is. The secondary appraisal involves the individual's assessment of his or her ability to cope, including an assessment of personal and physical resources. This secondary appraisal is often equated to Bandura's concept of self-efficacy (Bandura 1977) . Once an individual has appraised the situation, he or she then employs his or her coping skills. These coping skills can include emotion-focused approaches (for example avoidance, magical thinking), problem-focused strategies (changing behaviors), and utilization of social support systems. According to the stress coping model (Lazarus 1984) , the application of coping skills results in an outcome that prompts new appraisals, sparks new applications of skills, and so on. In this way coping is conceptualized not as a static event but as a process that unfolds in a cyclic pattern.
In the stress management model, treatment is oriented toward changing specific aspects of the carer situation that have been linked with carer stress, namely increasing their understanding of the patient's disease, improving their management of problem behaviors, and helping them to identify and use more informal and formal supports.
The interventions based on CBT typically include cognitive reframing as part of the intervention. In this context, the cognitive reframing element focuses on family carers' maladaptive, selfdefeating or distressing cognitions about their relatives' behaviors and their own performance in the caring role. It aims to alter these cognitions directly, making them better adapted to the situation. The differences in the theories underlying these three approaches are minor. CBT is the most structured model. The CBT interventions were psycho-educational in nature and included: targeted skill training (teaching, and helping carers to practise distinct selfmanagement skills) (Coon 2003); skills to cope with caring stress 
Risk of bias in included studies
All included studies were randomised controlled trials, but the randomisation technique was only mentioned by three authors (Hebert 2003; Hepburn 2005; Marriott 2000) . Baseline data were compared in all studies except in Zarit 1987. As argued earlier, performance bias is difficult to prevent in psychosocial intervention trials but detection bias can be prevented by blinding of outcome assessors. This was reported in nearly 50% of the studies. The attrition rate was reported in nearly all studies. Intention-totreat analysis was rarely used. The results are shown in Table 1 . Process analysis or intervention dosage has been conducted by a few authors, which indicates whether the intervention has actually been carried out as intended. Only Chang 1999 (registration of telephone call) and Zarit 1987 (a supervision meeting in which an audiotape of a session with a caregiver was reviewed) reported process analyses.
Outcome measures
Anxiety
1. State-Trait Anxiety Inventory (STAXI) asks participants how anxious they feel 'right now' by using a 4-point Likert scale, from 3 (very much) to 0 (not at all).
2. The Hamilton Anxiety Scale (HAMA) is a clinician-rated interview used to assess the presence or absence of symptoms associated with anxiety. The measure contains 14 separate interview items evaluating the level of anxiety experienced over the past month through the use of a 5-point severity scale (i.e. none, mild, moderate, severe, and very severe; range 0 to 56).
3. The Brief Symptom Inventory (BSI) (Derogatis 1982) is composed of 53 items that assess the frequency with which subjects have experienced various psychiatric symptoms during the previous seven days. Each item of the BSI is rated on a 5point scale of distress (0 to 4), ranging from 'not-at-all' to 'extremely'. The anxiety subscale was used. 3. Beck Depression Inventory (BDI) (Beck1988) consists of 21 items assessing depression through a 4-point scale (range 0 to 63); the total score is derived. 4. BSI (see above), the depression subscale was used.
Depression
Stress
1. Revised Burden Interview (BI) (Zarit 1982): the BI consists of 22 items that assess the caregiver's perception of the impact the involvement with the patient has had on his or her own life. Prior studies have demonstrated good reliability and validity of this instrument (Zarit 1982).
2. 10-item Perceived Stress Scale, derived from the 14-item scale (Cohen1983), measures overall appraisals of stress in the past month. It has been psychometrically tested and used in many studies with family carers of people with dementia. It assesses how unpredictable, uncontrollable, and overloaded respondents find their lives. Items are rated on 5-point Likert scales (0: never, and 4: very often).
3. Two studies (Beauchamp 2005; Hepburn 2005) used investigator-developed stress or distress scales.
Carer burden
1. The Zarit Burden Interview (Zarit 1985) , also referred to as the Revised Burden Interview (BI) (Zarit 1982), is a 22-item scale measuring the subjective load experienced by the caregiver by asking him or her how frequently (0: never, to 4: almost always) they feel various emotions in their relationship with their relative with dementia, for a total score out of 88. Scores between 8 and 17 represent a moderate burden, scores between 18 and 32 represent high burden, and scores over 32 represent severe burden. This measure provides a direct assessment of the carer's appraisal of the impact that caring for their relative has had on his or her life.
2. Caregiver Strain Instrument was developed by the Benjamin Rose Research Institute (Bass 1998). Fourteen selfreport questions begin with the stem "During the past 4 weeks, because of helping the patient, I felt . . .". Responses include items that assess carer health, relationship strain, and mastery of skills on a 5-point Likert scale, with answers ranging from 5 (strongly agree) to 0 (strongly disagree).
Coping or self-efficacy
1. The Ways of Coping Checklist-Revised (WCCL-R) (Vitaliano 1985) . This measure produces subscales that reflect use of different coping strategies: 'Problem Solving', 'Count Your Blessings', 'Support Focused', 'Avoidance', 'Wishful Thinking', 'Blame Self ', 'Blame Others', and 'Religious Coping'. The 'Positive Coping' subscale was used in the Coon 2003 study and 'Coping-total' in the Beauchamp 2005 study.
2. Ways of Coping. Caregiver coping was assessed using the 48-item coping scale (Moos 1992). The scale measures different types of coping, with eight subscales that measure approach (problem-solving) or avoidance (emotion-focused) coping responses. Higher scores indicate more frequent use of the response. Internal consistency in the present study was 0.77 for the total scale, 0.68 for problem-focused, and 0.65 for emotionfocused coping.
3. Caregiving Competence (Pearlin 1990) . Caregivers responded to six brief scales reporting on their own perceptions of relational deprivation, role captivity, loss of self, caregiving competence, management of meaning, and caregiving mastery (the data are not reported for the last scale).
Revised Memory and Behavior Problem Checklist (RMBPC-reaction)
1. The Revised Memory and Behavior Problem Checklist, developed by Teri 1992, measures the frequency of behavioral and memory problems, and the reactions that these problems generate in the informal carer. The 24 items describe behaviors and participants score their frequency during the preceding week (on a scale from 0: never to 4: every day) and the extent to which this problem disturbed or upset them (on a scale from 0: not at all to 4: extremely).
Quality of life
Although several instruments have been developed to assess quality of life, these measures were not used in the included studies.
Healthcare utilization
For outcomes of the person with dementia, including residential care or number of general practice visits. The only healthcare utilization outcome in the included studies for the person with dementia was institutionalisation.
Effects of interventions
Analyses were performed on the combined results of the trials, except for the healthcare utilization outcomes.
Anxiety
The combined results from the included trials (Akkerman 2004; Beauchamp 2005; Chang 1999; Hebert 2003) reporting change in anxiety indicated a significant benefit from treatment (standardised mean difference (SMD) -0.21; 95% confidence interval (CI) -0.39 to -0.04) in reducing anxiety (Figure 1) .
Figure 1. Forest plot of comparison: Anxiety
Depression
The combined results from the included trials (Beauchamp 2005; Chang 1999; Coon 2003; Gallagher-Thompson 2007; Marquez-Gonzalez 2007; Marriott 2000) reporting change in depression indicated a significant benefit from treatment (SMD -0.66; 95% CI -1.27 to -0.05) in reducing depression ( Figure  2 ). There was considerable heterogeneity between the trials, with Coon's study showing the highest effect size but all studies favoring the intervention group. Therefore, we performed a subgroup analysis without the Coon 2003 study. The heterogeneity effect disappeared (Chi 2 = 2.53, df = 4, P = 0.64, I 2 = 0%) while the intervention effect remained significant (SMD -0.24; 95% CI -0.42 to -0.07). 
Carer burden
Neither the combined result nor the individual studies ( Beauchamp 2005; Hebert 2003; Hepburn 2005; Zarit 1987) showed a significant benefit from treatment in reducing burden (SMD -0.14; 95% CI -0.32 to 0.03) (Figure 3) . 
Coping or self-efficacy
The combined results from the included trials (Beauchamp 2005; Chang 1999; Coon 2003; Hepburn 2005) showed no significant benefit from treatment on coping or self-efficacy (SMD 0.64; 95% CI -0.17 to 1.45) (Figure 4) . 
Stress or distress related to caregiving
The combined results from the included trials (Beauchamp 2005; Gallagher-Thompson 2007; Hepburn 2005; Zarit 1987 ) reporting change in stress or distress indicated a significant benefit from treatment (SMD -0.24; 95% CI -0.40 to -0.07) ( Figure 5 ). 
RMBPC-reaction Revised Memory and Behavior Problem Checklist (RMBPC-reaction)
The combined results from the included trials (Hebert 2003; Marquez-Gonzalez 2007; Zarit 1987) showed no significant benefit from treatment in RMBPC-reaction (SMD -0.21; 95% CI -0.45 to 0.03) ( Figure 6 ). 
Institutionalization
The only available measure of healthcare utilization was institutionalization, and this appeared in only one study. No significant results of cognitive reframing on institutionalization were found.
D I S C U S S I O N
This systematic review and meta-analysis of cognitive reframing for family carers of persons with dementia showed beneficial effects over usual care for psychological morbidity (anxiety, depression) and (dis)stress. No effects were found for coping or self-efficacy, carer burden, reaction to the relative's behavior and institutionalization.
Consistent with our hypothesis, a positive effect on psychological morbidity was found. This is in accordance with the findings of Gale 2000. In contrast to our hypothesis, there is no evidence for the impact of cognitive reframing on burden or reaction to the relative's behavior, nor on coping or self-efficacy.
Focusing on the trials using a specific component of psychosocial interventions, in this case cognitive reframing, contributes to our knowledge of how psychosocial interventions work. Our data support the general cognitive reframing model, showing positive effects on psychological morbidity and (dis)stress. Our data help us to refine the results of other reviews which indicated that interventions producing positive effects generally are tailor-made and multi-component (Brodaty 2003; Spijker 2008 ) by suggesting the use of cognitive reframing as a valuable component in dealing with psychological morbidity and stress.
While process analysis could be used to examine how cognitive reframing interventions are actually used, and point to factors which prompt or impede their use, in the studies reviewed there was little evidence of process analyses having been conducted.
Ensuring the validity of trials examining the effectiveness of psychosocial interventions poses a greater challenge than ensuring the validity of pharmacological trials. There is a greater risk of contamination in psychosocial research as patients in the control group may become informed about the intervention and its content and be influenced by this information. The inclusion of studies using intention-to-treat analyses does not take into account the effect of attrition. It is useful to report findings from both the intention-totreat analysis and analysis for just those people who were exposed to the intervention.
Following our inclusion criteria strictly, we excluded the study of Whitlatch 1995 in which participants were differentiated by baseline scores, and more positive results were found. The different results arose because the investigators in this study ran analyses including only people who demonstrated significant levels of depression and burden at baseline. When participants who do not show significant levels of depression and burden are also included, there is less potential for the intervention to improve these outcomes.
Since there are several limitations to this review, our conclusions should be treated with caution. Although the quality of the studies is mainly satisfactory, as yet blinding of the assessor and intentionto-treat analysis are not common practice in psychosocial research. The number of included participants is modest, as is the number of included studies. Therefore, we might have missed true differences between subgroups. Heterogeneity exists regarding the participants' demographics (for example spouse or adult child carers), types of dementia in patients, intervention delivery methods, and outcome measures. However, the relatively low numbers of participants did not permit conclusions about differential effectiveness regarding relevant subgroups such as spousal and non-spousal carers.
The selection of studies remains a major issue for this review. None of the retrieved studies were specifically trials of cognitive reframing and selection of the studies for inclusion involved an element of subjective judgment about trials in which identifying and modifying participants' relevant beliefs was a specific, main aim of the intervention. We attempted to minimize this by having three authors assess the studies independently against a careful definition of 'cognitive reframing' and by having an external arbitrator de-cide in cases of disagreement. However, we acknowledge that some of the excluded multi-component studies may have used similar components.
The most important strength of the present review is the homogeneity of the theoretical framework across the selected trials; all included studies utilized cognitive reframing as the main component in their intervention, be it informed by the stress coping model, the stress management model or the CBT model.
A U T H O R S ' C O N C L U S I O N S Implications for practice
In clinical practice, cognitive reframing could be a useful additional tool in individualised support for carers of people with dementia. Cognitive reframing is individualised in the sense that it focuses on the personal attributions of the carer and stimulates personal change in appraisals. Although potentially influenced by many factors, a carer's change in appraisals is ultimately a personal process. Its individualised nature makes cognitive reframing applicable to a variety of caring situations and problems.
Implications for research
The present review adds further refinement to these conclusions in that it points to cognitive reframing as an effective underlying mechanism for reducing informal caregivers' psychological morbidity and stress. We hypothesize that cognitive reframing operates primarily through carers' attributions about personal strength and resilience. In future research this hypothesis can be empirically tested, thereby contributing to a systematic accumulation of knowledge on the mechanisms of action underlying psychosocial interventions. A challenge for future research is to further refine methodologies for trials of psychosocial interventions, including controlled designs with a lower risk of contamination.
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